Data Presented at the 2020 ADA Scientific Sessions Show that Patients Treated with Cirius Therapeutics’ MSDC-0602K Showed Improved Insulin Handling

Print Friendly, PDF & Email

PSOTIVE CLINICAL RESULTS FOR INSULIN MGT IN NASH & TYPE 2 DIABETES: SAN DIEGO and KALAMAZOO, Mich., June 15, 2020 /PRNewswire/ — Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases, today announced the presentation of clinical data at the virtual American Diabetes Association’s (ADA) 80 th […]